- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 284 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 188 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2026
- 471 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Report
- April 2023
- 117 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- February 2026
- 50 Pages
Global
From €2321EUR$2,650USD£2,014GBP
- Report
- February 2026
- 50 Pages
Global
From €2321EUR$2,650USD£2,014GBP
- Report
- February 2026
- 50 Pages
Global
From €2321EUR$2,650USD£2,014GBP
- Report
- February 2026
- 50 Pages
Global
From €2321EUR$2,650USD£2,014GBP
Hydroxyzine is a medication used to treat mental disorders, such as anxiety, tension, and agitation. It is a sedative-hypnotic drug, meaning it has a calming effect on the central nervous system. It is also used to treat nausea, vomiting, and itching. Hydroxyzine is available in both oral and injectable forms. It is generally well-tolerated, with few side effects.
Hydroxyzine is used to treat a variety of mental disorders, including anxiety, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and bipolar disorder. It is also used to treat insomnia, as well as nausea and vomiting associated with chemotherapy.
Hydroxyzine is a popular choice for treating mental disorders due to its effectiveness and low risk of side effects. It is available in generic and brand-name forms, and is often prescribed in combination with other medications.
Some companies in the Hydroxyzine market include Pfizer, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more